Company / Working Capital per Share
IGC Pharma, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.01
FY2025
5-year range
$0.01 / $0.54
FY2021-FY2025
Trend
-69.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $0.54 in FY2021 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -54.4%.
Declined from $0.09 to $0.01 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -69.0%
- 5-Year CAGR
- -54.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 69.3% year-over-year.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -69.3% |
| FY2024 | $0.03 | -71.3% |
| FY2023 | $0.09 | -66.2% |
| FY2022 | $0.26 | -50.7% |
| FY2021 | $0.54 | +34.4% |
| FY2020 | $0.40 | -52.4% |
| FY2019 | $0.84 | +2665.1% |
| FY2018 | $0.03 | -69.2% |
| FY2017 | $0.10 | -80.1% |
| FY2016 | $0.49 | -68.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026